Your browser doesn't support javascript.
loading
Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation.
Lalonde, Arthur; Bobic, Mislav; Winey, Brian; Verburg, Joost; Sharp, Gregory C; Paganetti, Harald.
Afiliação
  • Lalonde A; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, USA. Electronic address: alalonde@mgh.harvard.edu.
  • Bobic M; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, USA; ETH Zürich, Zürich, Switzerland.
  • Winey B; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, USA.
  • Verburg J; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, USA.
  • Sharp GC; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, USA.
  • Paganetti H; Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, USA.
Radiother Oncol ; 159: 39-47, 2021 06.
Article em En | MEDLINE | ID: mdl-33741469
ABSTRACT
BACKGROUND/

PURPOSE:

Setup variations and anatomical changes can severely affect the quality of head and neck intensity-modulated proton therapy (IMPT) treatments. The impact of these changes can be alleviated by increasing the plan's robustness a priori, or by adapting the plan online. This work compares these approaches in the context of head and neck IMPT. MATERIALS/

METHODS:

A representative cohort of 10 head and neck squamous cell carcinoma (HNSCC) patients with daily cone-beam computed tomography (CBCT) was evaluated. For each patient, three IMPT plans were created 1- a classical robust optimization (cRO) plan optimized on the planning CT, 2- an anatomical robust optimization (aRO) plan additionally including the two first daily CBCTs and 3- a plan optimized without robustness constraints, but online-adapted (OA) daily, using a constrained spot intensity re-optimization technique only.

RESULTS:

The cumulative dose following OA fulfilled the clinical objective of both the high-risk and low-risk clinical target volumes (CTV) coverage in all 10 patients, compared to 8 for aRO and 4 for cRO. aRO did not significantly increase the dose to most organs at risk compared to cRO, although the integral dose was higher. OA significantly reduced the integral dose to healthy tissues compared to both robust methods, while providing equivalent or superior target coverage.

CONCLUSION:

Using a simple spot intensity re-optimization, daily OA can achieve superior target coverage and lower dose to organs at risk than robust optimization methods.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia de Intensidade Modulada / Terapia com Prótons / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia de Intensidade Modulada / Terapia com Prótons / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2021 Tipo de documento: Article